BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 11129571)

  • 1. Expression of human cytochromes P450 1A1 and P450 1A2 as fused enzymes with yeast NADPH-cytochrome P450 oxidoreductase in transgenic tobacco plants.
    Shiota N; Kodama S; Inui H; Ohkawa H
    Biosci Biotechnol Biochem; 2000 Oct; 64(10):2025-33. PubMed ID: 11129571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herbicide-resistant tobacco plants expressing the fused enzyme between rat cytochrome P4501A1 (CYP1A1) and yeast NADPH-cytochrome P450 oxidoreductase.
    Shiota N; Nagasawa A; Sakaki T; Yabusaki Y; Ohkawa H
    Plant Physiol; 1994 Sep; 106(1):17-23. PubMed ID: 7972515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of atrazine in transgenic tobacco cell culture expressing human P450.
    Bode M; Stöbe P; Thiede B; Schuphan I; Schmidt B
    Pest Manag Sci; 2004 Jan; 60(1):49-58. PubMed ID: 14727741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation of metamitron by human p450 expressed in transgenic tobacco cell cultures.
    Bode M; Haas M; Faymonville T; Thiede B; Schuphan I; Schmidt B
    J Environ Sci Health B; 2006; 41(3):201-22. PubMed ID: 16484082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
    Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional expression of fused enzymes between human cytochrome P4501A1 and human NADPH-cytochrome P450 oxidoreductase in Saccharomyces cerevisiae.
    Wittekindt NE; Würgler FE; Sengstag C
    DNA Cell Biol; 1995 Apr; 14(4):273-83. PubMed ID: 7710684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herbicide resistance of transgenic rice plants expressing human CYP1A1.
    Kawahigashi H; Hirose S; Ohkawa H; Ohkawa Y
    Biotechnol Adv; 2007; 25(1):75-84. PubMed ID: 17156966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering herbicide metabolism in tobacco and Arabidopsis with CYP76B1, a cytochrome P450 enzyme from Jerusalem artichoke.
    Didierjean L; Gondet L; Perkins R; Lau SM; Schaller H; O'Keefe DP; Werck-Reichhart D
    Plant Physiol; 2002 Sep; 130(1):179-89. PubMed ID: 12226498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and expression in Saccharomyces cerevisiae of tobacco NADPH-cytochrome P450 oxidoreductase cDNA.
    Yamada T; Imaishi H; Oka A; Ohkawa H
    Biosci Biotechnol Biochem; 1998 Jul; 62(7):1403-11. PubMed ID: 9720224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
    Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
    Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase.
    Sengstag C; Eugster HP; Würgler FE
    Carcinogenesis; 1994 May; 15(5):837-43. PubMed ID: 8200084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice.
    Arlt VM; Levová K; Bárta F; Shi Z; Evans JD; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Stiborová M
    Chem Res Toxicol; 2011 Oct; 24(10):1710-9. PubMed ID: 21932800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, purification, and characterization of a catalytically active human cytochrome P450 1A2:rat NADPH-cytochrome P450 reductase fusion protein.
    Parikh A; Guengerich FP
    Protein Expr Purif; 1997 Apr; 9(3):346-54. PubMed ID: 9126606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen.
    Stiborová M; Sopko B; Hodek P; Frei E; Schmeiser HH; Hudecek J
    Cancer Lett; 2005 Nov; 229(2):193-204. PubMed ID: 16125300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a novel host, high-red yeast that stably expresses hamster NADPH-cytochrome P450 oxidoreductase: usefulness for examination of the function of mammalian cytochrome P450.
    Ohgiya S; Goda T; Hoshino T; Kamataki T; Ishizaki K
    Arch Biochem Biophys; 1997 Jul; 343(2):215-24. PubMed ID: 9224733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2.
    Stiborová M; Frei E; Wiessler M; Schmeiser HH
    Chem Res Toxicol; 2001 Aug; 14(8):1128-37. PubMed ID: 11511187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of detergents on rat CYP1A1-dependent monooxygenase: comparison of mixed and fused systems consisting of rat CYP 1A1 and yeast NADPH-P450 reductase.
    Inouye K; Kondo S; Yamamura M; Nakanishi D; Sakaki T
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1346-51. PubMed ID: 11162677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic rice plants expressing human CYP1A1 remediate the triazine herbicides atrazine and simazine.
    Kawahigashi H; Hirose S; Ohkawa H; Ohkawa Y
    J Agric Food Chem; 2005 Nov; 53(22):8557-64. PubMed ID: 16248553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
    Chun YJ; Kim MY; Guengerich FP
    Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrostatic interaction between cytochrome P450 and NADPH-P450 reductase: comparison of mixed and fused systems consisting of rat cytochrome P450 1A1 and yeast NADPH-P450 reductase.
    Kondo S; Sakaki T; Ohkawa H; Inouye K
    Biochem Biophys Res Commun; 1999 Apr; 257(2):273-8. PubMed ID: 10198202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.